Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supplemental oxygen versus room air during experimental hypovolemia
2021-003238-35Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxygen in hypovolemia (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Effect of supplemental oxygen on cardiac output during lower body negative pressure. Started Jun 2021; status: completed.
02
Drugs
oxygen
03
Conditions
hypovolemia
Beyond the preview
Go deeper on 2021-003238-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003238-35.